Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhuhai Trinomab Pharmaceutical Co Days Payable?
Zhuhai Trinomab Pharmaceutical CoSHSE:688806 -4.38%2 Days Payable is 812.69 as of Dec. 2025, which is 44% below its 10-year median of 1,458.55. GuruFocus rates SHSE:688806 with a GF Score™ of 2/100. The stock has 7 warning signs investors should review. Among 927 Drug Manufacturers companies, Zhuhai Trinomab Pharmaceutical Co ranks better than 96.22% on this metric.
The historical rank and industry rank for Zhuhai Trinomab Pharmaceutical Co's Days Payable or its related term are showing as below:
SHSE:688806'
s Days Payable Range Over the Past 10 Years
Min: 812.69 Med: 1458.55 Max: 4644.3
Current: 812.69
During the past 4 years, Zhuhai Trinomab Pharmaceutical Co's highest Days Payable was 4644.30. The lowest was 812.69. And the median was 1458.55.
SHSE:688806's Days Payable is ranked better than 96.22% of 927
companies
in the Drug Manufacturers industry
Industry Median: 88.13
vs SHSE:688806: 812.69
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhuhai Trinomab Pharmaceutical Co Days Payable Chart
Zhuhai Trinomab Pharmaceutical Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Days Payable
4,644.30
0.00
1,458.55
812.69
Zhuhai Trinomab Pharmaceutical Co Semi-Annual Data
Dec22
Dec23
Dec24
Dec25
Days Payable
4,644.30
0.00
1,458.55
812.69
SHSE:688806 vs ZTS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Zhuhai Trinomab Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhuhai Trinomab Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhuhai Trinomab Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Zhuhai Trinomab Pharmaceutical Co's Days Payable falls into.
Zhuhai Trinomab Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) has a Days Payable of 812.69 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhuhai Trinomab Pharmaceutical Co and its competitors. This is 44% below median its historical median of 1,458.55. Over the past decade, Zhuhai Trinomab Pharmaceutical Co's Days Payable has ranged from 812.69 to 4,644.30. According to the industry distribution chart, Zhuhai Trinomab Pharmaceutical Co ranks #35 out of 927 companies in the Drug Manufacturers industry, placing it in the top 3.8%.
Is Zhuhai Trinomab Pharmaceutical Co's Days Payable too high?
Zhuhai Trinomab Pharmaceutical Co's current Days Payable of 812.69 is 44% below median its 10-year median of 1,458.55. Over the past 10 years, this metric has ranged from a low of 812.69 to a high of 4,644.30. The Drug Manufacturers industry median Days Payable is 88.13. Zhuhai Trinomab Pharmaceutical Co's value of 812.69 is 822.1% above this industry median. Based on the distribution chart, Zhuhai Trinomab Pharmaceutical Co ranks #35 out of 927 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Zhuhai Trinomab Pharmaceutical Co has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Zhuhai Trinomab Pharmaceutical Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhuhai Trinomab Pharmaceutical Co ranks #35 out of 927 companies for Days Payable. This places Zhuhai Trinomab Pharmaceutical Co in the top 4% of its industry — outperforming the majority of peers. The industry median Days Payable is 88.13. Zhuhai Trinomab Pharmaceutical Co's value of 812.69 is 822.1% above this benchmark. Historically, Zhuhai Trinomab Pharmaceutical Co's own Days Payable has ranged from 812.69 to 4,644.30 over the past decade. While the company's 10-year median is 1,458.55 vs. the industry median of 88.13, Zhuhai Trinomab Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.13, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhuhai Trinomab Pharmaceutical Co's current Days Payable of 812.69 is 822.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhuhai Trinomab Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhuhai Trinomab Pharmaceutical Co's current Days Payable is 812.69, which is 44% below median its own 10-year median of 1,458.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhuhai Trinomab Pharmaceutical Co stock overvalued right now?
Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) has a current Days Payable of 812.69. The current Days Payable is 812.69, which is 44% below median its 10-year median of 1,458.55 and 822.1% above the Drug Manufacturers industry median of 88.13. Zhuhai Trinomab Pharmaceutical Co's overall GF Score™ is 2/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhuhai Trinomab Pharmaceutical Co (SHSE:688806), the current Days Payable is 812.69 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688806 has been successfully added to your 
